Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:formerName |
gptkb:Sankyo_Co.,_Ltd.
|
| gptkbp:founded |
1899
|
| gptkbp:headquarters |
gptkb:Tokyo,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sankyo
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:mergedInto |
gptkb:Daiichi_Sankyo
|
| gptkbp:notableProduct |
gptkb:olmesartan
statins |
| gptkbp:parentCompany |
gptkb:Daiichi_Sankyo
|
| gptkbp:website |
https://www.daiichisankyo.com/
|
| gptkbp:bfsParent |
gptkb:Naloxone
|
| gptkbp:bfsLayer |
6
|